Surfeit of stem cell stories in Nature and around
I'm at the ISSCR meeting in Barcelona, taking notes on talks and conversations. Writing that up is on the to-do list for tonight. Meanwhile, here's a quick plug for NPG. The 2 July issue of Nature is packed with stem cell content. The two stacks of free copies disappeared from the venue's literature tables before the first set of talks finished. For those of you who didn't arrive early enough, here's what was in that issue, along with a few stories that appeared online since then.
News stories
Sperm-like cells made from human embryonic stem cells
But results are only preliminary, researchers caution.
US stem-cell research expands
Biomedical agency announces new funding policy for cell lines.
Chief scientist quits California stem-cell agency
Departure raises questions over leadership at flagship centre.
Letter to the editor
We must reverse the Bush legacy of stem-cell problems
US researchers rely on very few lines; the NIH should consider what diversity is desired
Review by Shinya Yamanaka
Elite and stochastic models for induced pluripotent stem cell generation Can any cell be reprogrammed to pluripotency?
Research papers
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
See related Nature Reports story:Gene therapy combined with reprogramming makes disease-free cells
Cells keep a memory of their tissue origin during axolotl limb regeneration
See related Nature Reports story: Regenerating limb tissue may not dedifferentiate
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
Nature Reports provides a peek into peer review for this paper
A Nature news story on the cells being studied in clinical trials for heart disease
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
See a related Nature Reports story: A tale of two LIFs
NatureJobs article
Multiple fates: Despite the economic downturn, US universities are seeking faculty members with stem-cell expertise. That doesn't mean times are easy.
